Hepatology International

, Volume 8, Issue 3, pp 352–364

Comparison of first- and second-wave DAAs for HCV GT1: efficacy, safety, tolerability, and regimen complexity

  • Blaire E. Burman
  • Paul Y. Kwo
  • Kris V. Kowdley
Review Article

DOI: 10.1007/s12072-014-9552-6

Cite this article as:
Burman, B.E., Kwo, P.Y. & Kowdley, K.V. Hepatol Int (2014) 8: 352. doi:10.1007/s12072-014-9552-6

Keywords

Hepatitis CDirect-acting antivirals

Copyright information

© Asian Pacific Association for the Study of the Liver 2014

Authors and Affiliations

  • Blaire E. Burman
    • 1
  • Paul Y. Kwo
    • 2
  • Kris V. Kowdley
    • 3
  1. 1.Division of Gastroenterology & Hepatology, Department of MedicineUniversity of CaliforniaSan FranciscoUSA
  2. 2.Division of Gastroenterology & Hepatology, Department of MedicineIndiana UniversityIndianapolisUSA
  3. 3.Benaroya Research InstituteUniversity of WashingtonSeattleUSA